Immune and toxic mechanisms in drug-induced agranulocytosis
Pisciotta, A.V.
Seminars in Hematology 10(4): 279-310
1973
ISSN/ISBN: 0037-1963 PMID: 4139755 Document Number: 59748
Document emailed within 1 workday
Related Documents
Lawińska-Stankiewiczowa; Wszelaczyńska-Szaszkiewi 1973: Drug-induced agranulocytosis Wiadomosci Lekarskie 26(16): 1497-1501Kuhnowski, F.éd.ér.; Bauters, F. 2005: Management of drug-induced agranulocytosis La Revue du Praticien 55(6): 671-675
Płusa, T.; Frank-Piskorska, A.; Kaszyński, H. 1983: Lung abscess in drug-induced agranulocytosis Pneumonologia Polska 51(10): 525-530
Mintz, U.; Shaklai, M.; Pinkhas, J.; de Vries, A. 1975: Drug-induced agranulocytosis. a survey of twenty-three episodes Medecine Interne 13(3): 205-208
Rose, M.S.; Leahy, M.F.; Stevens, A.; Black, P.J.; Barkhan, P. 1972: The bone marrow during recovery from drug induced agranulocytosis Guy's Hospital Reports 121(2): 147-153
Pavithran, K.; Thomas, M. 2002: Hematopoietic growth factors in drug-induced agranulocytosis Journal of the Association of Physicians of India 50(5): 679-681
Gracheva, N.M. 1974: Medicamentous agranulocytosis as a manifestation of drug induced disease Terapevticheskii Arkhiv 46(1): 98-105
Hospers, G.A.; de Wolf, J.T.; Hazenberg, B.P.; Vellenga, E. 1993: Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis Nederlands Tijdschrift Voor Geneeskunde 137(42): 2152-2154
Sgro, C.; Escousse, A.; Dumas, M.; Guy, H.; Larcher, F.; Sattonet, C.; Giraud, C. 1982: Drug induced granulopenia and agranulocytosis. A polycentric study conducted by the association of French Pharmacovigilance Centers Therapie 37(4): 363-370
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115
Alfaro, J.; Berdichevsky, E.; Conte, G.; Tellez, C. 1994: A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection Revista Medica de Chile 122(6): 694-698
Rouveix, B.; Lassoued, K.; Regnier, B. 1988: Beta lactam-induced neutropenia: toxic or immune mechanism? Therapie 43(6): 489-492
Kunz, H.D. 1979: Allergic-toxic agranulocytosis Münchener Medizinische Wochenschrift 121(50): 32
Leibetseder, F. 1971: Toxic and drug-induced hemolytic anemias Wiener Medizinische Wochenschrift 121(45): 813-815
Takimoto, R.; Takamori, K. 2004: Drug induced toxic epidermal necrolysis Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 5): 515-518
Rutka, J.; Alberti, P.W. 1984: Toxic and drug-induced disorders in otolaryngology Otolaryngologic Clinics of North America 17(4): 761-774
Weisser, M. 1997: Toxic drug-induced proximal myopathy in CDC C3 HIV-infection Praxis 86(43): 1708-1710
Russi, E. 1992: Toxic and drug-induced lesions of the pulmonary parenchyma Schweizerische Rundschau für Medizin Praxis 81(19): 618-621
Weaver, C.H.; Huddleston, H.M.; Kingsley, M.M.; Wolverton, S.E. 2009: Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis Journal of Drugs in Dermatology: Jdd 8(11): 1031-1033
Gerl, A.; Wilmanns, W. 1993: Drug-induced immune hemocytopenias Deutsche Medizinische Wochenschrift 118(27-28): 1048